Sources of heterogeneity, specifically the type of TPO-RA, the grade of thrombocytopenia, the different number of cancer types, and the duration of TPO-RA treatment of each study were explored but, failed to reach statistical significance (p > 0.05). The gene discussed is TPO; the disease is Thrombocytopenia.